Stay updated on ONO-4538 in NSCLC Clinical Trial

Sign up to get notified when there's something new on the ONO-4538 in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ONO-4538 in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The study details page shows no significant additions or deletions; core content such as arms, outcomes, and locations remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T21:05:11.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Core content updated to v3.2.0 with a government-operating-status notice and a removal of the previous v3.1.0 marker.
    Difference
    3%
    Check dated 2025-10-06T05:20:45.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    - Added Revision: v3.1.0 to indicate a new version. - Removed several MedlinePlus topics: Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs, and Revision: v3.0.2. - Overall, the page now signals a new version while stripping specific topic entries related to drug safety/quality.
    Difference
    0.4%
    Check dated 2025-09-29T03:02:34.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-14T19:00:40.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T14:48:36.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has added significant information regarding drug safety and detailed locations for clinical trials, including specific cities in Japan, South Korea, and Taiwan. Additionally, it includes new publications related to cancer treatment.
    Difference
    15%
    Check dated 2025-08-31T11:47:25.000Z thumbnail image

Stay in the know with updates to ONO-4538 in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ONO-4538 in NSCLC Clinical Trial page.